Home » Market News » DirectorsTalk Highlights » INTERVIEW: Evgen Pharma plc CEO Stephen Franklin Maiden Results, Phase II updates & News to come
Evgen Pharma Plc

INTERVIEW: Evgen Pharma plc CEO Stephen Franklin Maiden Results, Phase II updates & News to come

Evgen Pharma plc (LON:EVG) CEO Stephen Franklin caught up with DirectorsTalk to discuss the company’s maiden results, the two phase II trials and when we can expect them to report and news flow over the coming year.

 

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.